Clinical Trial Update: Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low-dose ticagrelor to low-dose prasugrel in patients with prior myocardial infarction; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Myocardial Infarction
• Renal Disease

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Attikon Hospital | Conditions: Myocardial Infarction, Diabetes Mellitus | Phase 4 | Status: COMPLETED